New drug combo aims to free CML patients from lifelong pills
Disease control
Recruiting now
This study tests whether adding a newer drug called asciminib to standard CML medications can help patients achieve and maintain a medication-free period. It is for adults with chronic-phase CML who previously tried to stop their medication but saw their cancer markers return. Th…
Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC